"The transparency of clinical studies is of key importance to patient safety: it makes possible a comprehensive evaluation of the benefits offered by medical products, for example. This text explores the advantages and disadvantages of the possible Transatlantic Free Trade Agreement (TTIP) in the field of health policy and calls for the policy of transparency that has applied to clinical studies to date to be preserved and maintained."